mtm laboratories Inc.: p16 Immuno-Cytochemistry Shows Superior Clinical Performance To HPV Testing for the Identification of High-Grade CIN Harbored In ASC-US And LSIL Pap Cytology Cases
HEIDELBERG, Germany--(BUSINESS WIRE)--mtm laboratories, a fully integrated cancer diagnostics company with proprietary products marketed globally, today announced the publication of a large study in the July issue of the American Journal of Clinical Pathology that evaluated the clinical performance of the CE-labeled CINtec® Cytology kit in managing equivocal or mildly abnormal cytologic results.